Clearpoint Neuro Inc
NASDAQ:CLPT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Clearpoint Neuro Inc
Free Cash Flow
Clearpoint Neuro Inc
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Clearpoint Neuro Inc
NASDAQ:CLPT
|
Free Cash Flow
-$24.4m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-11%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Free Cash Flow
$3.7B
|
CAGR 3-Years
57%
|
CAGR 5-Years
30%
|
CAGR 10-Years
35%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Free Cash Flow
$1.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
16%
|
CAGR 10-Years
12%
|
|
|
Stryker Corp
NYSE:SYK
|
Free Cash Flow
$4.3B
|
CAGR 3-Years
28%
|
CAGR 5-Years
9%
|
CAGR 10-Years
20%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Free Cash Flow
$7.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
15%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Free Cash Flow
$2.5B
|
CAGR 3-Years
37%
|
CAGR 5-Years
17%
|
CAGR 10-Years
13%
|
|
Clearpoint Neuro Inc
Glance View
Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 80 full-time employees. The company went IPO on 2019-07-03. The Company’s product platforms include SmartFlow Cannula and ClearPoint Navigation System Software. The SmartFlow Cannula is being utilized in approved combination product clinical and preclinical studies by pharmaceutical companies and academic research customers for various research and clinical trials in connection with delivery of therapeutic agents. The ClearPoint Navigation System Software is a software for surgical planning, navigation to target, and device delivery. The Company’s software and MRI-compatible workstation coordinate with the scanner to effectively utilize intraprocedural MR images. This provides real-time navigational instruction for the neurosurgeon to reach the desired anatomical target with a high degree of precision.
See Also
What is Clearpoint Neuro Inc's Free Cash Flow?
Free Cash Flow
-24.4m
USD
Based on the financial report for Dec 31, 2025, Clearpoint Neuro Inc's Free Cash Flow amounts to -24.4m USD.
What is Clearpoint Neuro Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-11%
Over the last year, the Free Cash Flow growth was -165%. The average annual Free Cash Flow growth rates for Clearpoint Neuro Inc have been -12% over the past three years , -24% over the past five years , and -11% over the past ten years .
